MICHAEL BIENER: Open Payments
NPI 1538849708 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,035 in 114 payments from 16 companies in 2025. Trend: 2023 $380 · 2024 $1,405 · 2025 $2,035
Food & beverage: $1,792Education: $243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $439 |
| Janssen Biotech, Inc. | 10 | $307 |
| Galderma Laboratories, L.P. | 36 | $297 |
| Novartis Pharmaceuticals Corporation | 7 | $133 |
| UCB, Inc. | 4 | $131 |
| Lilly USA, LLC | 6 | $119 |
| Regeneron Healthcare Solutions, Inc. | 2 | $117 |
| Incyte Corporation | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 5 | $80 |
| LEO Pharma Inc. | 3 | $77 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, RINVOQ, DUPIXENT, Bimzelx, TALTZ, AKLIEF.
Industry payments across NY — which companies pay providers there.
